Partnering with mid-sized pharma

Partnering with mid-sized pharma

Altana
ALT is developing therapeutics in oncology and for respiratory and gastrointestinal disorders. ALT's pharma group has 7,504 employees. The group reported 2002 R&D expenses of E335 million ($351 million), which represented 18% of pharma sales.
Pharma deals Date Deal type
Aventis 4/01 Develop and market ALT respiratory compound in U.S.
Pharmacia

Read the full 578 word article

How to gain access

Continue reading with a
two-week free trial.